Pages that link to "Q44675420"
The following pages link to Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. (Q44675420):
Displaying 50 items.
- Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination (Q26765345) (← links)
- Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer (Q28066486) (← links)
- Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets (Q28076161) (← links)
- Myeloid-derived suppressor cells as regulators of the immune system (Q28131637) (← links)
- Myeloid-derived cells are key targets of tumor immunotherapy (Q28388246) (← links)
- Coordinated regulation of myeloid cells by tumours (Q28395157) (← links)
- The role of myeloid-derived suppressor cells in immune ontogeny (Q28654584) (← links)
- Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity (Q33598739) (← links)
- Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer (Q33606107) (← links)
- The vitamin D connection to pediatric infections and immune function (Q34078700) (← links)
- Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling (Q34079557) (← links)
- Targeting immune suppressing myeloid-derived suppressor cells in oncology. (Q34082067) (← links)
- All-trans retinoic acid in combination with primaquine clears pneumocystis infection (Q34545112) (← links)
- Molecular pathways: myeloid complicity in cancer (Q34725969) (← links)
- Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men. (Q35036628) (← links)
- The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity (Q35675017) (← links)
- Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma (Q35915614) (← links)
- 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells (Q35915769) (← links)
- Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck (Q35922983) (← links)
- Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis (Q36102797) (← links)
- Role of immature myeloid cells in mechanisms of immune evasion in cancer (Q36208862) (← links)
- Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. (Q36249153) (← links)
- Protective mechanisms of head and neck squamous cell carcinomas from immune assault (Q36311985) (← links)
- Myeloid derived suppressor cells in human diseases (Q36338349) (← links)
- Toward a core nutraceutical program for cancer management (Q36473648) (← links)
- Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction (Q36476085) (← links)
- Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia (Q36644639) (← links)
- Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer (Q36896764) (← links)
- Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer. (Q37017190) (← links)
- Myeloid-derived suppressor cells: natural regulators for transplant tolerance (Q37019136) (← links)
- Immune-checkpoint blockade and active immunotherapy for glioma (Q37420586) (← links)
- Myeloid-Derived Suppressor Cells in Human Cancer (Q37778697) (← links)
- Camouflage and sabotage: tumor escape from the immune system (Q37882478) (← links)
- Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients (Q37961577) (← links)
- Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention (Q38016208) (← links)
- Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines. (Q38154151) (← links)
- Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer (Q38165930) (← links)
- Inflammation and pancreatic cancer: disease promoter and new therapeutic target (Q38167608) (← links)
- Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets (Q38269370) (← links)
- Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer (Q38528814) (← links)
- The immunobiology of myeloid-derived suppressor cells in cancer (Q38649547) (← links)
- Myeloid-derived suppressor cells: The green light for myeloma immune escape. (Q38821941) (← links)
- On the origin of myeloid-derived suppressor cells. (Q38968944) (← links)
- The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients. (Q38971075) (← links)
- The restoration of myeloid‐derived suppressor cells as functional antigen‐presenting cells by NKT cell help and all‐trans‐retinoic acid treatment (Q39478416) (← links)
- Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer (Q41110098) (← links)
- Combination docetaxel plus vitamin D(3) as an immune therapy in animals bearing squamous cell carcinomas (Q46743215) (← links)
- Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives (Q47651773) (← links)
- Targeting Myeloid-Derived Suppressor Cells in Cancer (Q47765346) (← links)
- CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D. (Q52677584) (← links)